ABSTRACT
Interface engineering is essential for cellulosic fiber-reinforced polymer composites to achieve high strength and toughness. In this study, carboxymethyl cellulose (CMC) functionalized with hydrophobic quaternary ammonium ions (QAs) were utilized to modify the interface between holocellulose fibers (HF) and acrylic resin. The wet HF/CMC papers were prepared by vacuum filtration, akin to papermaking, followed by cationic ion exchange with different hydrophobic QAs. Subsequently, the modified papers were dried, impregnated with an acrylic resin monomer, and cured to produce transparent composite films. The effect of the hydrophobic QA moieties on the structure and optical and mechanical properties of the HF/CMC/acrylic resin composites were investigated. The composite film with cetyltrimethylammonium (CTA)-functionalized CMC showed high optical transmittance (87%) with low haze (43%), while the composite film with phenyltrimethylammonium (PTMA)-functionalized CMC demonstrated high Young's modulus of 7.6 GPa and high tensile strength of 180 MPa. These properties are higher than those of the composites prepared through covalent interfacial modification strategies. The results highlighted the crucial role of hydrophobic functionalized CMCs in facilitating homogeneous resin impregnation in the HF fiber network, producing a composite with enhanced interfacial adhesion strength, increased optical transparency, and mechanical strength. This facile use of hydrophobic CMCs as interfacial compatibilizers provides an energy-efficient route for preparing transparent, thin, and flexible composite films favorable in optoelectronic applications.
Subject(s)
Acrylic Resins , Carboxymethylcellulose Sodium , Hydrophobic and Hydrophilic Interactions , Tensile Strength , Carboxymethylcellulose Sodium/chemistry , Acrylic Resins/chemistry , Quaternary Ammonium Compounds/chemistry , Cellulose/chemistry , Elastic ModulusABSTRACT
BACKGROUND: Triple negative BCa (TNBC) is defined by a lack of expression of estrogen (ERα), progesterone (PgR) receptors and human epidermal growth factor receptor 2 (HER2) as assessed by protein expression and/or gene amplification. It makes up ~ 15% of all BCa and often has a poor prognosis. TNBC is not treated with endocrine therapies as ERα and PR negative tumors in general do not show benefit. However, a small fraction of the true TNBC tumors do show tamoxifen sensitivity, with those expressing the most common isoform of ERß1 having the most benefit. Recently, the antibodies commonly used to assess ERß1 in TNBC have been found to lack specificity, which calls into question available data regarding the proportion of TNBC that express ERß1 and any relationship to clinical outcome. METHODS: To confirm the true frequency of ERß1 in TNBC we performed robust ERß1 immunohistochemistry using the specific antibody CWK-F12 ERß1 on 156 primary TNBC cancers from patients with a median of 78 months (range 0.2-155 months) follow up. RESULTS: We found that high expression of ERß1 was not associated with increased recurrence or survival when assessed as percentage of ERß1 positive tumor cells or as Allred > 5. In contrast, the non-specific PPG5-10 antibody did show an association with recurrence and survival. CONCLUSIONS: Our data indicate that ERß1 expression in TNBC tumours does not associate with prognosis.
Subject(s)
Breast Neoplasms , Triple Negative Breast Neoplasms , Humans , Female , Estrogen Receptor beta/genetics , Estrogen Receptor alpha/genetics , Triple Negative Breast Neoplasms/metabolism , Breast Neoplasms/drug therapy , Tamoxifen/therapeutic use , Prognosis , Receptors, Estrogen , Receptor, ErbB-2/therapeutic use , Receptors, Progesterone/metabolismABSTRACT
Temperature is a fundamental parameter for all forms of lives. Natural evolution has resulted in organisms which have excellent thermoregulation capabilities in extreme climates. Bioinspired materials that mimic biological solution for thermoregulation have proven promising for passive radiative cooling. However, scalable production of artificial photonic radiators with complex structures, outstanding properties, high throughput, and low cost is still challenging. Herein, we design and demonstrate biologically inspired photonic materials for passive radiative cooling, after discovery of longicorn beetles' excellent thermoregulatory function with their dual-scale fluffs. The natural fluffs exhibit a finely structured triangular cross-section with two thermoregulatory effects which effectively reflects sunlight and emits thermal radiation, thereby decreasing the beetles' body temperature. Inspired by the finding, a photonic film consisting of a micropyramid-arrayed polymer matrix with random ceramic particles is fabricated with high throughput. The film reflects â¼95% of solar irradiance and exhibits an infrared emissivity >0.96. The effective cooling power is found to be â¼90.8 Wâ m-2 and a temperature decrease of up to 5.1 °C is recorded under direct sunlight. Additionally, the film exhibits hydrophobicity, superior flexibility, and strong mechanical strength, which is promising for thermal management in various electronic devices and wearable products. Our work paves the way for designing and fabrication of high-performance thermal regulation materials.
ABSTRACT
In order to stabilize the extinction cross section measurement of a single nanoparticle, we propose to analyze the blurriness parameter of aperture edge images in real time, which provides a feedback to lock the sample position. Unlike the conventional spatial modulation spectroscopy (SMS) technique, a probe beam experiences both the spatial modulation by a piezo stage and the temporal modulation by a chopper. We experimentally demonstrate that the measurement uncertainty is one order magnitude less than that in the previous report. The proposed method can be readily implemented in conventional SMS systems and can help to achieve high stability for sensing based on light extinction by a single nanoparticle, which alleviate the impact from laboratory environment and increase the experimental sensitivity.
ABSTRACT
Metamaterials with spectrally selective absorptance operating in the mid-infrared range have attracted much interest in numerous applications. However, it remains a challenge to economically fabricate scalable meta-absorbers with tailorable absorptance bands. This work demonstrates a conceptually simple and low-cost yet effective design strategy to achieve spectrally selective absorption with tailorable band positions at MIR by colloidal lithography. The strategy ingeniously uses residual diameter fluctuations of circular resonators etched through monodisperse colloidal particles for achieving superposition of multiple magnetic resonances and thereby a more than doubled absorption band, which is neglected in previous works. The proposed meta-absorber features densely packed thick aluminum resonators with a rather narrow diameter distribution and enhanced capacitive coupling among them. Moreover, the tailorability of the absorption band can be achieved by a parameterized variation in the fabrication process. As a proof of concept, infrared stealth and radiative cooling are demonstrated based on our meta-absorbers. The design and fabrication strategy create versatile metamaterials for advanced radiative thermal engineering.
ABSTRACT
Adiabatic multimode Y-junctions are extensively used for the design of multimode silicon photonics devices due to their straightforward principle in achieving mode splitting and manipulation. However, experimentally, the limited feature size achievable by lithography can greatly deteriorate the adiabatic branching property and result in large excess loss and crosstalk. Here, we propose a branch structure consisting of a circular-hole-based chirped subwavelength slot. By optimizing the holes' radii and positions under our fabrication constraint, we designed and experimentally demonstrated both symmetric and asymmetric approximately adiabatic four-mode Y-junctions with excellent performance close to ideal Y-junctions over a broad wavelength span. Such junctions are compact, CMOS-compatible, exhibit a relatively large fabrication tolerance, and could be extended for more modes; hence they can be potentially deployed for mode-division multiplexing silicon-photonic systems.
ABSTRACT
We report on the study of polarization properties of light propagating through transparent wood (TW), which is an anisotropically scattering medium, and consider two cases: completely polarized and totally unpolarized light. It was demonstrated that scattered light distribution is affected by the polarization state of incident light. Scattering is the most efficient for light polarized parallel to cellulose fibers. Furthermore, unpolarized light becomes partially polarized (with a polarization degree of 50%) after propagating through the TW. In the case of totally polarized incident light, however, the degree of polarization of transmitted light is decreased, in an extreme case to a few percent, and reveals an unusual angular dependence on the material orientation. The internal hierarchical complex structure of the material, in particular cellulose fibrils organized in lamellae, is believed to be responsible for the change of the light polarization degree. It was demonstrated that the depolarization properties are determined by the angle between the polarization of light and the wood fibers, emphasizing the impact of their internal structure, unique for different wood species.
ABSTRACT
BACKGROUND: While a number of studies have examined miRNA profiles across the molecular subtypes of breast cancer, it is unclear whether BRCA1 basal-like cancers have a specific miRNA profile. This study aims to compare grade independent miRNA expression in luminal cancers, sporadic and BRCA1 basal-type breast cancers. It also aims to ascertain an immunohistochemical profile regulated by BRCA1 specific miRNAs for potential diagnostic use. METHODS: miRNA expression was assessed in 11 BRCA1 basal, 16 sporadic basal, 17 luminal grade 3 cancers via microarrays. The expression of Cyclin D1, FOXP1, FIH-1, pan-ERß, NRP1 and CD99, predicted to be regulated by BRCA1 specific miRNAs by computer prediction algorithms, was assessed via immunohistochemistry in a cohort of 35 BRCA1 and 52 sporadic basal-like cancers. Assessment of cyclin D1, FOXP1, NRP1 and CD99 expression was repeated on a validation cohort of 82 BRCA1 and 65 sporadic basal-like breast cancers. RESULTS: Unsupervised clustering of basal cancers resulted in a "sporadic" cluster of 11 cancers, and a "BRCA1" cluster of 16 cancers, including a subgroup composed entirely of 10 BRCA1 cancers. Compared with sporadic basal cancers, BRCA1 cancers showed reduced positivity for proteins predicted to be regulated by miRNAs: FOXP1 (6/20[30 %] vs. 37/49[76 %], p < 0.001), cyclin D1 (8/22[36 %] vs. 30/46[65 %], p = 0.025), NRP1 (2/20[10 %] vs. 23/46[50 %], p = 0.002). This was confirmed in the validation cohort (all p < 0.001). Negative staining for 2 or more out of FOXP1, cyclin D1 and NRP1 predicts germline BRCA1 mutation with a sensitivity of 92 %, specificity of 44 %, positive predictive value of 38 % and a negative predictive value of 94 %. CONCLUSION: Sporadic and BRCA1 basal-like cancers have grade independent miRNA expression profiles. Furthermore miRNA driven differences in the expression of proteins in BRCA1 basal cancers may be detected via immunohistochemistry. These findings may have important diagnostic implications, as immunohistochemical assessment of basal cancers, in addition to the patient's family and clinical history, may potentially identify patients who may benefit from BRCA1 gene testing.
Subject(s)
Breast Neoplasms/genetics , Genes, BRCA1 , Genetic Association Studies , MicroRNAs/genetics , Mutation , Neoplasms, Basal Cell/genetics , Transcriptome , Biomarkers, Tumor , Breast Neoplasms/pathology , Cluster Analysis , Female , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Gene Regulatory Networks , Humans , Immunohistochemistry , Neoplasm Grading , Neoplasms, Basal Cell/pathology , RNA Interference , RNA, Messenger/geneticsABSTRACT
INTRODUCTION: The RAD21 gene encodes a key component of the cohesin complex, which is essential for chromosome segregation, and together with BRCA1 and BRCA2, for high-fidelity DNA repair by homologous recombination. Although its expression correlates with early relapse and treatment resistance in sporadic breast cancers, it is unclear whether familial breast cancers behave in a similar manner. METHODS: We performed an immunohistochemical analysis of RAD21 expression in a cohort of 94 familial breast cancers (28 BRCA1, 27 BRCA2, and 39 BRCAX) and correlated these data with genotype and clinicopathologic parameters, including survival. In these cancers, we also correlated RAD21 expression with genomic expression profiling and gene copy-number changes and miRNAs predicted to target RAD21. RESULTS: No significant differences in nuclear RAD21 expression were observed between BRCA1 (12 (43%) of 28), BRCA2 (12 (44%) of 27), and BRCAX cancers (12 (33%) of 39 (p = 0.598). No correlation was found between RAD21 expression and grade, size, or lymph node, ER, or HER2 status (all P > 0.05). As for sporadic breast cancers, RAD21 expression correlated with shorter survival in grade 3 (P = 0.009) and but not in grade 1 (P = 0.065) or 2 cancers (P = 0.090). Expression of RAD21 correlated with poorer survival in patients treated with chemotherapy (P = 0.036) but not with hormonal therapy (P = 0.881). RAD21 expression correlated with shorter survival in BRCA2 (P = 0.006) and BRCAX (P = 0.008), but not BRCA1 cancers (P = 0.713). Changes in RAD21 mRNA were reflected by genomic changes in DNA copy number (P < 0.001) and by RAD21 protein expression, as assessed with immunohistochemistry (P = 0.047). High RAD21 expression was associated with genomic instability, as assessed by the total number of base pairs affected by genomic change (P = 0.048). Of 15 miRNAs predicted to target RAD21, mir-299-5p inversely correlated with RAD21 expression (P = 0.002). CONCLUSIONS: Potential use of RAD21 as a predictive and prognostic marker in familial breast cancers is hence feasible and may therefore take into account the patient's BRCA1/2 mutation status.
Subject(s)
BRCA1 Protein/genetics , BRCA2 Protein/genetics , Breast Neoplasms/metabolism , Breast Neoplasms/mortality , Nuclear Proteins/metabolism , Phosphoproteins/metabolism , Biomarkers, Tumor/analysis , Biomarkers, Tumor/metabolism , Breast Neoplasms/drug therapy , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Cell Cycle Proteins , Cohort Studies , DNA-Binding Proteins , Female , Gene Expression Regulation, Neoplastic , Genomic Instability , Heterozygote , Humans , MicroRNAs/genetics , Middle Aged , Nuclear Proteins/genetics , Pedigree , Phosphoproteins/genetics , Predictive Value of Tests , Prognosis , Reproducibility of ResultsABSTRACT
INTRODUCTION: Basal-like breast cancers behave more aggressively despite the presence of a dense lymphoid infiltrate. We hypothesised that immune suppression in this subtype may be due to T regulatory cells (Treg) recruitment driven by hypoxia-induced up-regulation of CXCR4 in Treg. METHODS: Immunoperoxidase staining for FOXP3 and CXCL12 was performed on tissue microarrays from 491 breast cancers. The hypoxia-associated marker carbonic anhydrase IX (CA9) and double FOXP3/CXCR4 staining were performed on sections from a subset of these cancers including 10 basal-like and 11 luminal cancers matched for tumour grade. RESULTS: High Treg infiltration correlated with tumour CXCL12 positivity (OR 1.89, 95% CI 1.22 to 2.94, P = 0.004) and basal phenotype (OR 3.14, 95% CI 1.08 to 9.17, P = 0.004) in univariate and multivariate analyses. CXCL12 positivity correlated with improved survival (P = 0.005), whereas high Treg correlated with shorter survival for all breast cancers (P = 0.001), luminal cancers (P < 0.001) and basal-like cancers (P = 0.040) that were confirmed in a multivariate analysis (OR 1.61, 95% CI 1.02 to 2.53, P = 0.042). In patients treated with hormone therapy, high Treg were associated with a shorter survival in a multivariate analysis (OR 1.78, 95% CI 1.01 to 3.15, P = 0.040). There was a tendency for luminal cancers to show CXCL12 expression (102/138, 74%) compared to basal-like cancers (16/27, 59%), which verged on statistical significance (P = 0.050). Up-regulation of CXCR4 in Treg correlated with the basal-like phenotype (P = 0.029) and tumour hypoxia, as indicated by CA9 expression (P = 0.049). CONCLUSIONS: Our data show that in the setting of hypoxia and CXCR4 up-regulation in Treg, CXCL12 expression may have the negative consequence of enhancing Treg recruitment and suppressing the anti-tumour immune response.
Subject(s)
Breast Neoplasms/immunology , Cell Hypoxia , Receptors, CXCR4/biosynthesis , T-Lymphocytes, Regulatory/immunology , Adult , Aged , Aged, 80 and over , Antigens, Neoplasm/biosynthesis , Biomarkers, Tumor/analysis , Breast Neoplasms/mortality , Breast Neoplasms/pathology , Carbonic Anhydrase IX , Carbonic Anhydrases/biosynthesis , Chemokine CXCL12/biosynthesis , Female , Forkhead Transcription Factors/biosynthesis , Gene Expression Regulation, Neoplastic , Humans , Middle Aged , Neoplasm Invasiveness , Prognosis , T-Lymphocytes, Regulatory/metabolismABSTRACT
INTRODUCTION: RAD21 is a component of the cohesin complex, which is essential for chromosome segregation and error-free DNA repair. We assessed its prognostic and predictive power in a cohort of in situ and invasive breast cancers, and its effect on chemosensitivity in vitro. METHODS: RAD21 immunohistochemistry was performed on 345 invasive and 60 pure in situ carcinomas. Integrated genomic and transcriptomic analyses were performed on a further 48 grade 3 invasive cancers. Chemosensitivity was assessed in breast cancer cell lines with an engineered spectrum of RAD21 expression. RESULTS: RAD21 expression correlated with early relapse in all patients (hazard ratio (HR) 1.74, 95% confidence interval (CI) 1.06 to 2.86, P = 0.029). This was due to the effect of grade 3 tumors (but not grade 1 or 2) in which RAD21 expression correlated with early relapse in luminal (P = 0.040), basal (P = 0.018) and HER2 (P = 0.039) groups. In patients treated with chemotherapy, RAD21 expression was associated with shorter overall survival (P = 0.020). RAD21 mRNA expression correlated with DNA copy number, with amplification present in 32% (7/22) of luminal, 31% (4/13) of basal and 22% (2/9) of HER2 grade 3 cancers. Variations in RAD21 mRNA expression in the clinical samples were reflected in the gene expression data from 36 breast cancer cell lines. Knockdown of RAD21 in the MDA-MB-231 breast cancer cell line significantly enhanced sensitivity to cyclophosphamide, 5-fluorouracil and etoposide. The findings for the former two drugs recapitulated the clinical findings. CONCLUSIONS: RAD21 expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers. RAD21 may be a novel therapeutic target.
Subject(s)
Breast Neoplasms/genetics , Breast Neoplasms/pathology , Drug Resistance, Neoplasm/genetics , Nuclear Proteins/genetics , Phosphoproteins/genetics , Receptor, ErbB-2/metabolism , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Breast Neoplasms/drug therapy , Breast Neoplasms/mortality , Cell Cycle Proteins , Cell Line, Tumor , Cluster Analysis , DNA Copy Number Variations , DNA-Binding Proteins , Female , Gene Amplification , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Gene Silencing , Humans , Kaplan-Meier Estimate , Neoplasm Grading , Neoplasm Staging , Nuclear Proteins/metabolism , Phosphoproteins/metabolism , RNA, Small InterferingABSTRACT
Estrogen receptor (ER) α has been studied extensively in familial breast cancers but there are limited data on ERß and its isoforms. This is an important issue since many BRCA1-associated tumours are "triple negative" and are resistant to conventional and targeted therapies. We performed an immunohistochemical study of pan-ERß, ERß1 and ERß2 in a cohort of 123 familial breast carcinomas (35 BRCA1, 33 BRCA2 and 55 BRCAX) using a cut-off for positivity at 20% (Shaaban et al. in Clin Cancer Res 14:5228-5235, 2008). BRCA1 cancers were more likely to be nuclear ERα negative and nuclear pan-ERß positive (21/32, 66%) when compared with BRCA2 (2/29, 7%) and BRCAX cancers (11/49, 22%) (both P < 0.001). For survival analysis, expression was also stratified using cut-offs defined by Bates et al. (Breast Cancer Res Treat 111:453-459, 2008) (score out of 7). Cytoplasmic ERß2 expression correlated with shorter overall survival at 15 years regardless of cut-off used (both P < 0.046) At a cut-off score of 6 out of 7, cytoplasmic ERß2 expression correlated with a poorer response to chemotherapy in both univariate (P = 0.011) and multivariate analyses including grade, lymph node status and chemotherapy as an interaction variable (P = 0.045, Hazard ratio 1.22, 95% CI 1.004-9.87). A similar trend was seen in a univariate analysis with a cut-off of 20% although this did not reach statistical significance (P = 0.057). Expression of nuclear ERß1 was associated with a favourable response to endocrine therapy at 15 years regardless of cut-offs employed (both P < 0.025). However, this did not reach statistical significance in a multivariate analysis (P > 0.05). Since a significant proportion of ERα negative familial breast carcinomas are positive for nuclear ERß1 and cytoplasmic ERß2, the different ERß isoforms and their intracellular location may need to be assessed, to identify patients that may benefit from hormonal and chemotherapy.
Subject(s)
Breast Neoplasms/diagnosis , Cell Nucleus/metabolism , Cytoplasm/metabolism , Estrogen Receptor beta/metabolism , Adult , Aged , Antineoplastic Agents/therapeutic use , BRCA1 Protein/metabolism , BRCA2 Protein/metabolism , Breast Neoplasms/drug therapy , Breast Neoplasms/genetics , Estrogen Receptor alpha/metabolism , Estrogen Receptor beta/genetics , Female , Genetic Association Studies , Humans , Kaplan-Meier Estimate , Middle Aged , Multivariate Analysis , Prognosis , Proportional Hazards Models , Protein Isoforms/genetics , Protein Isoforms/metabolism , Receptor, ErbB-2/metabolism , Receptors, Progesterone/metabolism , Tissue Array AnalysisABSTRACT
Phyllodes tumours and cellular fibroadenomas are both fibroepithelial tumours of the breast. Phyllodes tumours, unlike fibroadenomas, have the ability to recur and metastasise. Although these lesions can be distinguished by their stromal cellularity, mitotic index, presence or absence of stromal overgrowth and cellular atypia, there is overlap and not infrequently a definitive diagnosis cannot be made, particularly on biopsy. We sought to evaluate whether DNA promoter methylation profiling using selected genes known to be methylated in cancer would allow us to learn more about the biology of these tumours, and whether it could identify methylation markers that could differentiate phyllodes tumours from fibroadenomas and/or distinguish phyllodes tumours of different grades. Methylation-sensitive high resolution melting (MS-HRM) was used to screen promoter DNA methylation changes in 86 phyllodes tumours (15 benign, 28 borderline, 43 malignant) and 26 fibroadenomas. A panel of 11 genes (RASSF1A, TWIST1, APC, WIF1, MGMT, MAL, RARß, CDKN2A, CDH1, TP73 and MLH1) was tested. Methylation status was correlated with histology and with clinicopathological parameters. Five of the gene promoters showed some methylation in a proportion of phyllodes tumours; RASSF1A, 45.3%; TWIST1, 10.7%; APC, 4.1%; WIF1, 2.9% and MGMT, 1.3%. Only two genes showed any methylation in fibroadenomas usually at background levels; RASSF1A, 53.8% and MGMT, 8.3%. No CDKN2A methylation was observed in either tumour type, contrary to previous reports. Overall, the methylation patterns differed little from that which might be seen in normal cells. However, significant levels of methylation of RASSF1A (24.4%) and TWIST1 (7.1%) was observed in some phyllodes tumours. Elevated RASSF1A and/or TWIST1 methylation was significantly associated with phyllodes tumours compared with fibroadenomas (P = 0.02), TWIST1 methylation correlated with increasing malignancy in phyllodes tumours (P < 0.001). In conclusion, assessment of methylation of RASSF1A and TWIST1 may aid in the diagnosis of phyllodes tumours. The absence of frequent methylation in fibroadenomas supports a non-neoplastic origin.
Subject(s)
Biomarkers, Tumor/genetics , Breast Neoplasms/genetics , DNA Methylation , Fibroadenoma/genetics , Gene Expression Profiling , Genetic Markers , Phyllodes Tumor/genetics , Adolescent , Adult , Aged , Australia , Breast Neoplasms/pathology , Chi-Square Distribution , Female , Fibroadenoma/pathology , Gene Expression Profiling/methods , Humans , Logistic Models , Middle Aged , Nuclear Proteins/genetics , Phyllodes Tumor/pathology , Promoter Regions, Genetic , Risk Assessment , Risk Factors , Tumor Suppressor Proteins/genetics , Twist-Related Protein 1/genetics , Young AdultABSTRACT
Extensive expression profiling studies have shown that sporadic breast cancer is composed of five clinically relevant molecular subtypes. However, although BRCA1-related tumours are known to be predominantly basal-like, there are few published data on other classes of familial breast tumours. We analysed a cohort of 75 BRCA1, BRCA2 and non-BRCA1/2 breast tumours by gene expression profiling and found that 74% BRCA1 tumours were basal-like, 73% of BRCA2 tumours were luminal A or B, and 52% non-BRCA1/2 tumours were luminal A. Thirty-four tumours were also analysed by single nucleotide polymorphism-comparative genomic hybridization (SNP-CGH) arrays. Copy number data could predict whether a tumour was basal-like or luminal with high accuracy, but could not predict its mutation class. Basal-like BRCA1 and basal-like non-BRCA1 tumours were very similar, and contained the highest number of chromosome aberrations. We identified regions of frequent gain containing potential driver genes in the basal (8q and 12p) and luminal A tumours (1q and 17q). Regions of homozygous loss associated with decreased expression of potential tumour suppressor genes were also detected, including in basal tumours (5q and 9p), and basal and luminal tumours (10q). This study highlights the heterogeneity of familial tumours and the clinical consequences for treatment and prognosis.
Subject(s)
Breast Neoplasms/genetics , Gene Dosage , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Genetic Predisposition to Disease , BRCA1 Protein/genetics , BRCA2 Protein/genetics , Breast Neoplasms/pathology , Breast Neoplasms/therapy , Chromosome Aberrations , Cluster Analysis , Cohort Studies , Comparative Genomic Hybridization , DNA Methylation , Female , Gene Expression Profiling/methods , Heredity , Humans , Loss of Heterozygosity , Oligonucleotide Array Sequence Analysis , Pedigree , Polymorphism, Single Nucleotide , PrognosisABSTRACT
Refractive index (RI) determination for delignified wood templates is vital for transparent wood composite fabrication. Reported RIs in the literature are based on either single plant fibers or wood powder, measured by the immersion liquid method (ILM) combined with mathematical fitting. However, wood structure complexity and the physical background of the fitting were not considered. In this work, RIs of delignified wood templates were measured by the ILM combined with a light transmission model developed from the Fresnel reflection/refraction theory for composite materials. The RIs of delignified balsa wood are 1.536 ± 0.006 and 1.525 ± 0.008 at the wavelength of 589 nm for light propagating perpendicular and parallel to the wood fiber direction, respectively. For delignified birch wood, corresponding values are 1.537 ± 0.005 and 1.529 ± 0.006, respectively. The RI data for delignified wood scaffolds are important for tailoring optical properties of transparent wood biocomposites, and also vital in optical properties investigations by theoretical modelling of complex light propagation in transparent wood and related composites. The developed light transmission model in combination with the immersion liquid method can be used to determine the RI of complex porous or layered solid materials and composites.
ABSTRACT
Functional load-bearing materials based on phase-change materials (PCMs) are under rapid development for thermal energy storage (TES) applications. Mesoporous structures are ideal carriers for PCMs and guarantee shape stability during the thermal cycle. In this study, we introduce transparent wood (TW) as a TES system. A shape-stabilized PCM based on polyethylene glycol is encapsulated into a delignified wood substrate, and the TW obtained is fully characterized, also in terms of nano- and mesoscale structures. Transparent wood for thermal energy storage (TW-TES) combines large latent heat (â¼76 J g-1) with switchable optical transparency. During the heating process, optical transmittance increases by 6% and reaches 68% for 1.5 mm thick TW-TES. Characterization of the thermal energy regulation performance shows that the prepared TW-TES composite is superior to normal glass because of the combination of good heat-storage and thermal insulation properties. This makes TW-TES composites interesting candidates for applications in energy-saving buildings.
ABSTRACT
Transparent wood (TW) is an emerging optical material combining high optical transmittance and haze for structural applications. Unlike nonscattering absorbing media, the thickness dependence of light transmittance for TW is complicated because optical losses are also related to increased photon path length from multiple scattering. In the present study, starting from photon diffusion equation, it is found that the angle-integrated total light transmittance of TW has an exponentially decaying dependence on sample thickness. The expression reveals an attenuation coefficient which depends not only on the absorption coefficient but also on the diffusion coefficient. The total transmittance and thickness were measured for a range of TW samples, from both acetylated and nonacetylated balsa wood templates, and were fitted according to the derived relationship. The fitting gives a lower attenuation coefficient for the acetylated TW compared to the nonacetylated one. The lower attenuation coefficient for the acetylated TW is attributed to its lower scattering coefficient or correspondingly lower haze. The attenuation constant resulted from our model hence can serve as a singular material parameter that facilitates cross-comparison of different sample types, at even different thicknesses, when total optical transmittance is concerned. The model was verified with two other TWs (ash and birch) and is in general applicable to other scattering media.
ABSTRACT
We present a case of lower back pain with lumbar nerve compromise due to a ligamentum flavum haematoma which was successfully treated surgically. A 62-year-old man was evaluated for lower back pain with associated leg pain and early signs of cauda equina syndrome. MRI of the lumbar spine demonstrated a contrast-enhancing mass adjacent to the lamina of L3 which was causing severe canal stenosis. Surgical excision of the lesion was recommended. The patient underwent an L3 laminectomy with excision of the epidural lesion. Histopathology showed it to be a haematoma of the ligamentum flavum with no untoward features. The patient recovered without complication.